Abstract:Objective: To examine the effects of cytochrome P450 3A4 (CYP3A4), cytochrome P450 3A5 (CYP3A5) and ATP-binding cassette sub-family B member 1 (ABCB1) genetic polymorphisms on carbamazepine (CBZ) plasma concentrations in Chinese patients with epilepsy using CBZ as monotherapy and bitherapy with phenytoin (PHT), phenobarbital (PB), or valproic acid (VPA). Methods: Eighty-eight Chinese patients with epilepsy were recruited from Xiangya Hospital Central South University, of whom 66 patients were placed in the CBZ monotherapy group, 10 patients were placed in the CBZ bitherapy group combined with one enzyme-inducing anti-seizure medications (PHT or PB), and 12 patients were placed in the CBZ bitherapy group combined with VPA. Carbamazepine and carbamazepine-10,11-epoxide (CBZ-E) plasma concentration of these patients were measured. In addition, the genetic polymorphisms of rs4646440 and rs2242480 in the CYP3A4 gene, rs15524 and rs776746 in the CYP3A5 gene, and rs1045642, rs2032582, rs10234411 and rs1128503 in the ABCB1 gene of the cohort were genotyped. Subsequently, the associations between CBZ plasma concentrations and target single-nucleotide polymorphisms (SNPs), as well as haplotypes, were analysed. Results: In the CBZ monotherapy group, dose-adjusted CBZ concentrations were not associated with the eight SNPs and haplotypes. In the CBZ+PHT/PB group, rs776746, rs15524 and rs15524-rs776746 GT, AC haplotype were significantly associated with dose-adjusted CBZ plasma concentration (P=0.006, 0.006, 0.003, 0.003, respectively) and CBZ plus CBZ-E concentrations (P=0.006, 0.006, 0.006, 0.006, respectively); rs2032582, rs10234411 and rs2032582-rs10234411 AT, and CA haplotype were associated with the CBZ-E/CBZ ratio (P=0.007, 0.004, 0.004, 0.007, respectively). Conclusions: rs776746 and rs15524 in the CYP3A5 gene tend to affect CBZ metabolism, and rs2032582, rs10234411 in the ABCB1 gene may contribute to inter-individual variation in CBZ and in CBZ-E transport among patients with epilepsy using CBZ in combination with PHT or PB.

Affecting Factors of Serum Carbamazepine Concentrations in Children with Epilepsy

Analysis of Serum Concentration of Carbamazepine in 381 Cases

Effect of Cefazolin on Carbamazapine Serum Concentration in Children with Epilepsy

Analysis of the Influencing Factors of the Plasma Concentration of Oxcarbazepine Active Metabolite in Children with Epilepsy

Serum concentration analysis of oxcarbazepine active metabolite in children with epilepsy

Association Study of Cyp3a5 Genetic Polymorphism with Serum Concentrations of Carbamazepine in Chinese Epilepsy Patients

Blood Serum Concentration Monitoring for Oxcarbazepine Metabolites in 217 Children with Epilepsy

Association Study of the Efficacy Genetic with the Blood Concentration of Carbamazepine

Effects of CYP3A5 and UGT2B7 Variants on Steady-State Carbamazepine Concentrations in Chinese Epileptic Patients

Effect of Carbamazepine on Bone Mineral Density of Adult Epileptics

Effects of Carbamazepine on Plasma Concentrations of Valproic Acid and Its Toxic Metabolite in Epileptic Patients

Effects of CYP3A4/5 and ABCB1 genetic polymorphisms on carbamazepine metabolism and transport in Chinese patients with epilepsy treated with carbamazepine in monotherapy and bitherapy

Relationship Between Cytochromes P450 2C19 * 2 Genotype and the Concentration of the Active Oxcarbazepine Metabolite in Pediatric Patients with Epilepsy

Effects of Major Transporter and Metabolizing Enzyme Gene Polymorphisms on Carbamazepine Metabolism in Chinese Patients with Epilepsy

Saliva And Plasma Monohydroxycarbamazepine Concentrations In Pediatric Patients With Epilepsy

Correlative Aanalysis Between CYP3 A Activity,Concentration of Carbamazepine and Clinical Therapeutic Effect

Investigation of influence of valproic acid, phenytoin, phenobarbital to relative clearance of carbamazepine and its epoxide metabolite

ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients

Brain distribution and efficacy of carbamazepine in kainic acid induced seizure in rats.

Influence of age and combination of drugs on oxcarbazepine plasma concentration in patients with epilesy

Effect of carbamazepine and valproate on bone mineral density